2021
DOI: 10.1002/hed.26670
|View full text |Cite
|
Sign up to set email alerts
|

Diagnostic use of fine‐needle aspiration cytology and core‐needle biopsy in head and neck sarcomas

Abstract: The diagnostic role of fine‐needle aspiration cytology (FNAC) and core‐needle biopsy (CNB) has not been comprehensively assessed in head and neck sarcomas. A systematic review of published cases (1990–2020) was conducted. Diagnostic performance of both FNAC/CNB to determine tumor dignity and histopathological diagnosis was calculated. One hundred and sixty‐eight cases were included for which FNAC (n = 156), CNB (n = 8), or both (n = 4) were used. Predominant histologies were skeletal muscle, chondrogenic and v… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
3
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 38 publications
0
3
0
Order By: Relevance
“…The HNC diagnosis usually includes laryngoscopy, imaging [Positron emission tomography/X-ray computed tomography (PET/CT) and magnetic resonance imaging (MRI)], and biopsy of the primary lesion [ 31 , 32 , 33 , 34 , 35 ]. As technology progresses, the development of non-invasive diagnostic tools in the field of head and neck oncology has been examined; the molecular analysis of tumor’s genetic features based on circulating malignance derivatives, such as circulating tumor DNA, intact circulating tumor cells (CTCs), and exosomes in patients’ blood, namely liquid biopsy, has become a concrete possible approach to improve diagnostics, treatment planning, and post-treatment surveillance in patients with the potentially curable disease [ 36 , 37 , 38 , 39 ].…”
Section: Head and Neck Cancer And Alcoholmentioning
confidence: 99%
“…The HNC diagnosis usually includes laryngoscopy, imaging [Positron emission tomography/X-ray computed tomography (PET/CT) and magnetic resonance imaging (MRI)], and biopsy of the primary lesion [ 31 , 32 , 33 , 34 , 35 ]. As technology progresses, the development of non-invasive diagnostic tools in the field of head and neck oncology has been examined; the molecular analysis of tumor’s genetic features based on circulating malignance derivatives, such as circulating tumor DNA, intact circulating tumor cells (CTCs), and exosomes in patients’ blood, namely liquid biopsy, has become a concrete possible approach to improve diagnostics, treatment planning, and post-treatment surveillance in patients with the potentially curable disease [ 36 , 37 , 38 , 39 ].…”
Section: Head and Neck Cancer And Alcoholmentioning
confidence: 99%
“…Age, primary site, progression speed and imaging findings strongly support an accurate pathological diagnosis. A close dialogue between the clinician and the pathologist is important in enhancing diagnostic accuracy ( 30 , 31 ).…”
Section: Changes In Histopathological Diagnosis In the Genomic Eramentioning
confidence: 99%
“…FNAC is a minimally invasive way of obtaining diseased tissue and has achieved widespread application in the diagnosis of many sites and types of tumors (6)(7)(8). Combined with various assistive techniques, the correctness of the FNAC diagnosis is comparable to that of histopathological biopsy for some kinds of tumors (6,9). FNAC of suspicious lymph nodes also provides additional information on tumor staging, which can better guide subsequent treatment (10, 11).…”
mentioning
confidence: 99%